Theme: Expanding Present Vaccine Research Outcomes in the wake of Pandemic
VACCINE CONGRESS 2024
- About VACCINE CONGRESS 2024
- Why to Attend?
- Target Audience
- Sessions & Tracks
- Market Analysis
- Benefits of Participation
- Visa Trip Advisor
The highly anticipated "4th International Conference on Vaccine Research" is scheduled to take place from September 09-10, 2024, in the vibrant city of Madrid, Spain. This landmark event promises to be a hybrid experience, seamlessly blending in-person and virtual components to accommodate a diverse global audience. VACCINE CONGRESS 2024 aims to provide an inclusive platform for scientists, researchers, and vaccine advocates to converge, exchange ideas, and collectively advance the field of vaccine research with the theme of "Expanding Present Vaccine Research Outcomes in the Wake of Pandemic."
The agenda for VACCINE CONGRESS 2024 has been meticulously crafted, spanning two days dedicated to in-depth exploration of various facets of vaccine research. The inaugural day will kick off with a grand opening ceremony, setting an intellectually stimulating atmosphere. Esteemed keynote speakers from the realm of vaccine research will share their expertise, offering valuable insights into the latest advancements and challenges in vaccine development. Subsequent sessions will encompass a diverse array of scientific discussions, panel talks, and workshops, covering topics such as vaccine efficacy, immunology, public health implications, and ethical considerations.
In the face of ongoing health challenges, the significance of vaccine research has never been more pronounced. VACCINE CONGRESS 2024 stands at the forefront of this critical dialogue, propelling progress in vaccine science and shaping the trajectory of global health. We invite you to embark on this exciting journey with us at VACCINE CONGRESS 2024 and contribute to the collective effort of building a healthier, more resilient world.
This is your prime opportunity to engage with the largest gathering of professionals dedicated to vaccine research and development worldwide. Our diverse membership spans the globe, attracting individuals interested in the latest advancements in vaccine science and technology. The conference features renowned speakers, showcasing the latest methods, discoveries, and breakthroughs in vaccine research, including:
- Internationally recognized experts presenting cutting-edge research in vaccine development, immunology, and public health.
- Access to the most recent innovations in vaccine technology, including advancements in vaccination techniques and immunization strategies.
- In-depth discussions on topics such as vaccine efficacy, safety, and distribution, as well as ethical considerations in vaccine development.
- Opportunities to network with leading scientists, researchers, and practitioners in the field of vaccine research and development.
Join us for this two-day conference to:
- Present your research findings, share knowledge, and contribute to the advancement of vaccine science.
- Engage in discussions with pioneers in vaccine research, exchanging ideas and perspectives on the current challenges and opportunities in the field.
- Participate in interactive debates, plenary sessions, and workshops to gain insights into the latest trends and developments in vaccine research.
This conference provides a unique platform for professionals in the field of vaccine research to come together, exchange ideas, and collaborate on advancing vaccine science for the betterment of global health. Don't miss this opportunity to be part of the conversation and contribute to shaping the future of vaccine research and development.
- Vaccine Researchers
- Immunologists
- Microbiologists
- Public Health Specialists
- Epidemiologists
- Virologists
- Pharmacologists
- Vaccine Developers
- Clinical Researchers
- Healthcare Administrators
- Policy Makers in Public Health
- Pharmaceutical Industry Representatives
- Medical Practitioners
- Primary Care Physicians
- Specialists in Infectious Diseases
- Pediatricians
- Internal Medicine Physicians
- Nurses and Nurse Practitioners
- Health Educators
- Medical Students and Residents
- Biomedical Engineers
- Biostatisticians
- Ethicists in Healthcare
- Patient Advocates
- Global Health Organizations
- Academic Institutions in Health Sciences
- Government Health Agencies
- Non-Governmental Organizations (NGOs)
- Vaccine Manufacturers
- Biotechnology Companies
- Clinical Trial Organizations
- Medical Device Companies
- Healthcare Technology Providers
- Research Funding Agencies
Track 1. COVID19 Vaccines
COVID19 vaccines are pivotal tools in combating the global pandemic caused by the SARSCoV2 virus. Utilizing various technologies such as mRNA, viral vector, and protein subunit, these vaccines aim to induce immunity against the virus, thereby preventing severe illness and transmission.
- mRNA vaccines
- Vector vaccines
- Vaccine efficacy
- Vaccine distribution
- Vaccine hesitancy
- Booster doses
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Global Summit on Vaccine | Virology Meet | Euro Vaccine 2024 Conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024 | Vaccine Immunology
Related Societies:
Europe:
European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft fur Immunology
USA:
American Academy of Pediatrics ; American College Health Association ; Association of Immunization Managers ; Association for Professionals in Infection Control and Epidemiology
Asia and Middle-East:
Asia Pacific Association of Allergy, Asthma, and Clinical Immunology ; Asia Pacific Association of Pediatric Allergy, Respirology and Immunology ; Commonwealth of Independent States Society of Allergology and Immunology
Track 02: Vaccines Epidemiology
Vaccines epidemiology – Vaccines - A scientific field that works with testing methods and methods involved in vaccine testing is vaccine epidemiology. The overall purpose of the research field is to provide an understanding of the various methods and techniques involved in evaluating vaccines.
There is a growing increase in vaccines that guarantee life-saving interventions, and the use of epidemiological vaccines maximizes the benefits of this type of primary prevention.
- Vaccination
- Immunization
- Herd immunity
- Vaccine efficacy
- Vaccine safety
- Vaccine-preventable diseases
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine| Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024 | Vaccine Immunology
Related Societies:
Europe:
European Society for Pediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
The Anti-Vaccination Society of America; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society
Asia and Middle-East:
Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy
Track 03: Vaccines Immunology
Immunization is a worldwide wellbeing and advancement example of overcoming adversity, saving large number of lives each year. Antibodies diminish dangers of getting a sickness by working with your body's normal safeguards to construct security. At the point when you get an antibody, your resistant framework reacts.
We currently have immunizations to forestall in excess of 20 perilous illnesses, helping individuals of any age live more, better lives. Vaccination as of now forestalls 2-3 million passing consistently from sicknesses like diphtheria, lockjaw, pertussis, flu and measles.
- Immune response
- Antibodies
- Antigens
- Memory cells
- B cells
- T cells
- Adaptive immunity
- Innate immunity
- Humoral immunity
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Global Summit on Vaccine | Virology Meet | Euro Vaccine 2024 Conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024 | Vaccine Immunology
Related Societies:
Europe:
European Academy of Pediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development ; European malaria Vaccine Initiative
USA:
Autism Science Foundation ; Childhood Influenza Immunization Coalition ;Edward Jenner Vaccine Society; Global Polio Eradication Initiative
Asia and Middle-East:
Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology
Track 4. Vaccine Safety
Vaccine safety is paramount for public health programs. Rigorous monitoring, from preclinical trials through postmarket surveillance, ensures adverse events following immunization (AEFI) are promptly detected and managed. Pharmacovigilance systems track vaccine safety in real-world scenarios, maintaining public trust.
- Bcell immunity
- Tcell immunity
- Immune memory
- Vaccineinduced immune responses
- Immune correlates of protection
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Academy of Allergy and Clinical Immunology ; European Molecular Biology Laboratory ; Medical Research Council ; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Hepatitis B Foundation ; Infectious Diseases Society of America ; National Adult and Influenza Immunization Summit ; National Foundation for Infectious Diseases ; Pediatrics Infectious Diseases Society
Asia and Middle-East:
Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists
Track 5. Novel Vaccine Platforms
Innovative vaccine platforms, including mRNA, DNA, viral vectors, and recombinant protein vaccines, offer promising avenues for vaccine development. These platforms enhance efficacy, scalability, and antigen presentation, leading to broader vaccine applications.
- DNA vaccines
- Viruslike particles (VLPs)
- Recombinant protein vaccines
- Synthetic vaccines
- Nanoparticle vaccines
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences Global Summit on Vaccine | Virology Meet | Euro Vaccine 2024 Conferences |Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024 | Vaccine Immunology
Related Societies:
Europe:
European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft fur Immunology
USA:
American Academy of Pediatrics ; American College Health Association ; Association of Immunization Managers ; Association for Professionals in Infection Control and Epidemiology
Asia and Middle-East:
Asia Pacific Association of Allergy, Asthma and Clinical Immunology ; Asia Pacific Association of Pediatric Allergy, Respirology and Immunology ; Commonwealth of Independent States Society of Allergology and Immunology
Track 6. Immunology of Vaccines
Understanding vaccine induced immune responses is critical for optimizing vaccine design and efficacy. Vaccines stimulate both humoral and cellular immunity, leading to the production of antibodies and memory cells. Insights into immunological mechanisms guide vaccine development and administration strategies.
- Bcell immunity
- Tcell immunity
- Immune memory
- Vaccineinduced immune responses
- Immune correlates of protection
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024 | Vaccine Immunology
Related Societies:
Europe:
Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical Immunology; Finnish Society of Allergology and Clinical Immunology; French Society of Allergology and Clinical Immunology
USA:
Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, Asthma, and Immunology; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology
Asia and Middle-East:
Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology
Track 7. Vaccine Manufacturing
Efficient vaccine manufacturing is essential for global vaccine supply. Modern manufacturing technologies, such as cell based and recombinant methods, enhance scalability and flexibility. Supply chain management ensures timely distribution of vaccines to meet public health demands.
- Scale up production
- Vaccine supply chains
- Technology transfer
- Good Manufacturing Practices (GMP)
- Vaccine stability and storage
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine| Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical Immunology; Finnish Society of Allergology and Clinical Immunology; French Society of Allergology and Clinical Immunology
USA:
Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, ; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology
Asia and Middle-East:
Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology
Track 8. Vaccine Delivery Systems
Effective vaccine delivery systems ensure widespread immunization coverage. Innovations in delivery technologies, including needle free injections, microneedle patches, and oral vaccines, enhance vaccine accessibility and acceptability.
- Needlefree delivery
- Microneedle patches
- Oral vaccines
- Intranasal vaccines
- Biodegradable polymers
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Global Summit on Vaccine | Virology Meet | Euro Vaccine 2024 Conferences |Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft fur Immunologie
USA:
American Academy of Pediatrics ; American College Health Association ; Association of Immunization Managers ; Association for Professionals in Infection Control and Epidemiology
Asia and Middle-East:
Asia Pacific Association of Allergy, Asthma, and Clinical Immunology ; Asia Pacific Association of Pediatric Allergy, Respirology and Immunology ; Commonwealth of Independent States Society of Allergology and Immunology
Track 9. Vaccine Hesitancy
Vaccine hesitancy poses a significant challenge to public health efforts. Understanding the drivers of hesitancy, such as misinformation, mistrust, and complacency, is crucial for implementing targeted interventions to promote vaccine acceptance.
- Vaccine misinformation
- Trust in vaccines
- Vaccine confidence interventions
- Cultural and societal factors
- Vaccine communication strategies
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine| Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
British Society for Immunology; Microbiology Society, London; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; Society for Applied Microbiology; European Society of Clinical Microbiology and Infectious Diseases
USA:
The Federation of Clinical Immunology Societies; The American Association of Immunologists; American Society for Microbiology; Colombian Allergy, Asthma and Immunology Association; Canadian Society for Immunology
Asia and Middle-East:
Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology
Track 10. Global Vaccine Access
Ensuring equitable access to vaccines worldwide is essential for achieving global health security. Collaborative efforts between governments, international organizations, and pharmaceutical companies aim to address barriers to access, such as supply shortages and distribution inequities.
- Vaccine equity
- COVAX initiative
- Access to affordable vaccines
- Supply chain logistics
- Addressing barriers to access
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine |Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Societies; International; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy,Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clinical Immunology
Asia and Middle-East:
Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology
Track 11. Paediatric Vaccines
Paediatric vaccines protect children against various infectious diseases, reducing morbidity and mortality. Comprehensive vaccination schedules recommended by health authorities target diseases like measles, mumps, rubella, and polio.
- Childhood immunization schedule
- Combination vaccines
- Vaccine safety in children
- Immunization coverage rates
- Vaccines for new-borns and infants
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | | Virology Meet | Euro Vaccine 2024 Conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Academy of Pediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development ; European malaria Vaccine Initiative
USA:
Autism Science Foundation ; Childhood Influenza Immunization Coalition ; Edward Jenner Vaccine Society; Global Polio Eradication Initiative
Asia and Middle-East:
Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology
Track 12. Geriatric Vaccines
Geriatric vaccines safeguard the elderly population against vaccine preventable diseases. Vaccines targeting influenza, pneumococcal disease, and shingles reduce the burden of illness and complications in older adults.
- Vaccines for older adults
- Immunosenescence
- Vaccine effectiveness in the elderly
- Vaccination strategies for seniors
- Addressing age-related health conditions
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Academy of Allergy and Clinical Immunology ; European Molecular Biology Laboratory ; Medical Research Council ; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Hepatitis B Foundation ; Infectious Diseases Society of America ; National Adult and Influenza Immunization Summit ; National Foundation for Infectious Diseases ; Pediatrics Infectious Diseases Society
Asia and Middle-East:
Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists
Track 13. Vaccine Adjuvants
Vaccine adjuvants enhance immune responses to antigens, improving vaccine efficacy and duration of protection. Adjuvants such as aluminum salts, oilinwater emulsions, and tolllike receptor agonists stimulate innate immunity, leading to robust adaptive immune responses.
- Aluminum salts
- Liposomes
- Toll like receptor agonists
- Adjuvant systems
- Enhancing immune responses
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | | Virology Meet | Euro Vaccine 2024 Conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Academy of Allergy and Clinical Immunology ; European Molecular Biology Laboratory ; Medical Research Council ; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Hepatitis B Foundation ; Infectious Diseases Society of America ; National Adult and Influenza Immunization Summit ; National Foundation for Infectious Diseases ; Pediatrics Infectious Diseases Society
Asia and Middle-East:
Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists
Track 14. Vaccine Development for Emerging Diseases
Rapid vaccine development is critical in response to emerging infectious diseases. Innovative approaches, including platform technologies and accelerated clinical trials, enable timely vaccine deployment to contain outbreaks and prevent pandemics.
- Rapid response platforms
- Preclinical studies
- Pandemic preparedness
- Target identification
- Adaptive clinical trial design
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Society for Pediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology
USA:
The Anti-Vaccination Society of America; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society
Asia and Middle-East:
Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy
Track 15. Vaccine Immunogenicity
Vaccine immunogenicity refers to the ability of a vaccine to induce an immune response. Factors influencing immunogenicity include vaccine formulation, antigen design, and host factors such as age and immune status. Understanding immunogenicity is essential for evaluating vaccine efficacy and optimizing vaccination strategies.
- Humoral immune response
- Cellular immune response
- Immunogenicity assays
- Correlates of protection
- Vaccine antigen design
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
British Society for Allergy and Clinical Immunology; British Society for Histocompatibility and Immunogenetics; European Federation of Immunological Societies; European Academy of Allergology and Clinical Immunology
USA:
Voices for Vaccines ; National Institute of Allergy and Infectious Disease ; American Public Health Association ; American Association for the Advancement of Science ; American Society for Microbiology .
Asia and Middle-East:
Australasian Society for Immunology; Australasian Society of Clinical Immunology and Allergy; Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology
Track 16. Vaccine Policy and Regulation
Robust vaccine policies and regulations govern vaccine development, approval, and distribution. Regulatory agencies ensure vaccines meet safety and efficacy standards through rigorous evaluation of clinical data and manufacturing processes.
- Regulatory approval processes
- Vaccine licensure
- Vaccine mandates
- National immunization programs
- Postmarketing surveillance
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; International Union of Immunological Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology
Asia and Middle-East:
Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology
Track 17. Next Generation Vaccines
Nextgeneration vaccines leverage advanced technologies to improve vaccine efficacy, safety, and delivery. Innovations such as mRNA vaccines, nanoparticlebased vaccines, and synthetic biology offer promising avenues for developing vaccines against challenging pathogens.
- Personalized vaccines
- Synthetic biology approaches
- Multivalent vaccines
- Universal vaccines
- mRNA vaccine platforms
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | vaccine summit | Vaccines World 2024| Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2023| Vaccine Immunology
Related Societies:
Europe:
European Society for Pediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology
USA:
The Anti-Vaccination Society of America; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society
Asia and Middle-East:
Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy
Track 18. Vaccine Clinical Trials
Vaccine clinical trials assess the safety, immunogenicity, and efficacy of candidate vaccines in human populations. Phases of clinical trials, from initial testing in small groups to largescale efficacy trials, provide critical data for regulatory approval and public health decisionmaking.
- Phase I, II, III trials
- Randomized controlled trials
- Vaccine efficacy studies
- Safety monitoring
- Postlicensure studies
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences | Vaccine meet | vaccine expo | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clin Related Societies
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
Track 19. Vaccine Financing
Sustainable financing mechanisms are essential for vaccine research, development, and distribution. Publicprivate partnerships, donor funding, and innovative financing instruments support vaccine development efforts and ensure equitable access to vaccines worldwide.
- Global vaccine funds
- Publicprivate partnerships
- Vaccine procurement
- Health insurance coverage
- Costeffectiveness analyses
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences | Vaccine meet | vaccine expo | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clin Related Societies
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
Track 20. Vaccine Equity
Vaccine equity aims to ensure fair and impartial distribution of vaccines to all populations, regardless of socioeconomic status or geographic location. Addressing barriers to access, such as affordability, transportation, and vaccine hesitancy, promotes equitable vaccine coverage and reduces health disparities.
- Addressing disparities in access
- Community outreach programs
- Health equity initiatives
- Vaccine allocation strategies
- Equity in clinical trials
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; International Union of Immunological Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology
Asia and Middle-East:
Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology
Track 21. Vaccine Surveillance
Vaccine surveillance systems monitor vaccine preventable diseases and vaccine safety in real-time. Surveillance data inform public health interventions, outbreak response efforts, and vaccine policy decisions to protect population health.
- Disease surveillance systems
- Adverse event surveillance
- Vaccine preventable disease monitoring
- Vaccine coverage surveillance
- Real-time monitoring systems
Related Global Conferences:
World Vaccine Meets | Vaccine Conferences | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
European Academy of Allergy and Clinical Immunology ; European Molecular Biology Laboratory ; Medical Research Council ; Royal Society of London; Epidemiological Society of London; Edward Jenner Society
USA:
Hepatitis B Foundation ; Infectious Diseases Society of America ; National Adult and Influenza Immunization Summit ; National Foundation for Infectious Diseases ; Pediatrics Infectious Diseases Society
Asia and Middle-East:
Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists
Track 22. One Health Approach
The One Health approach recognizes the interconnectedness of human, animal, and environmental health. Vaccines developed using a One Health framework address zoonotic diseases and promote collaboration across sectors to mitigate emerging infectious disease threats.
- Zoonotic disease prevention
- Humananimalenvironment interface
- Crossspecies transmission
- Ecosystem health
- Interdisciplinary collaboration
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; International Union of Immunological Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology
Asia and Middle-East:
Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology
Track 23. Cancer BioMarker vaccine
A Cancer Biomarker Vaccine is a type of vaccine designed to target specific molecules, proteins, or genetic markers that are indicative of cancer cells. These biomarkers can be unique to cancer cells or overexpressed compared to normal cells, making them potential targets for therapy.
The concept behind this vaccine is to stimulate the body's immune system to recognize and attack cells displaying these specific biomarkers, thereby targeting and destroying cancerous cells while sparing healthy ones. Essentially, it's a form of immunotherapy, harnessing the body's own immune defenses to fight cancer.
Related Global Conferences:
World Vaccine Meets | Infectious and non-infectious Conferences | Virology Meet | Euro Vaccine 2024 Conferences| Vaccine Conferences| Global Summit on Vaccine | Vaccines World 2024 | Global vaccine conferences | Vaccines & Immunization 2024 | Immunology & Immunotherapies 2024| Vaccine Immunology
Related Societies:
Europe:
Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; Royal Society of London; Epidemiological Society of London; Edward Jenner Society; International Union of Immunological Society
USA:
Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology
Asia and Middle-East:
Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology
VACCINE CONGRESS 2024 The vaccines market is an important aspect of the healthcare industry, with an expected value of USD 28.28 billion by 2026, according to research by Technavio. This market includes two main types of vaccines: prophylactic vaccines, which help prevent diseases, and therapeutic vaccines, which are used to treat existing illnesses.
The market is segmented by geography, including North America, Europe, Asia, and the Rest of World (ROW). Various vendors are involved in the production and distribution of vaccines, including Astellas Pharma Inc., AstraZeneca Plc, and GlaxoSmithKline Plc, among others. It is crucial for individuals to have access to vaccines to prevent the spread of diseases and maintain overall health. The growing vaccines market indicates the importance of investing in and researching new vaccines to protect public health.
Types of participation
VACCINE CONGRESS 2024, provides the participants with different modes or ways to participate under either Academic / Student / Business Category
- Keynote speaker: 45-50 minutes
- Speaker (oral presentation): 25-30 minutes (only one person can present)
- Speaker (workshop): 45-50 minutes (more than 1 can present)
- Speaker (special session): 45-50 minutes (more than 1 can present)
- Speaker (symposium): more than 45 minutes (more than 1 can present)
- Delegate (only registration): will have access to all the sessions with all the benefits of registration
- Poster presenter: can present a poster and enjoy the benefits of delegate
- Remote attendance: can participate via virtual mode or video presentation or e-poster presentation
- Exhibitor: can exhibit his/her/their company’s products by booking exhibitor booths of different sizes
- Media Partner
- Sponsor
- Collaborator
Advantages of Participating in VACCINE CONGRESS 2024:
For Attendees:
1. Global Visibility: Your profile and abstract pages indexed by Google provide global visibility, fostering recognition in the vaccine research community.
2. Accessible Research: Our Library of Abstracts attracts over 30,000 visits monthly, facilitating exposure to cutting-edge research and attracting scholars and speakers.
3. Interactive Sessions: Engage in interactive meetings, ideal for networking and collaboration, especially for research teams.
4. Thought Leadership Exchange: Meet and exchange ideas with thought leaders in vaccine research, fostering intellectual growth and collaboration.
5. Recognition and Awards: Opportunities for receiving awards such as Young Scientist Award and Best Poster Certificates, acknowledging excellence in research.
6. Personalized Engagement: Engage in one-on-one discussions with distinguished speakers and keynote presenters, gaining personalized insights and inspiration.
7. Keynote Insights: Attend keynote presentations to gain insights from leading authorities in vaccine research, staying abreast of the latest discoveries.
Benefits for Speakers:
1. Publication Opportunity: All accepted abstracts will be published in reputable journals, contributing to scholarly dissemination and recognition.
2. Global Recognition: Gain admiration and recognition on a global scale for your contributions to vaccine research.
3. Professional Development: Discover cutting-edge analysis and advancements in the field, enriching your expertise and skills.
4. Networking and Collaboration: Forge lifelong connections through social and networking activities, fostering collaboration and growth.
5. Enhanced Visibility: Promote your research profile through distribution of abstract books and flyers, reaching a wide audience and enhancing visibility.
6. Diversified Learning: Explore new topics and studies beyond your primary focus, enriching your knowledge and broadening your research horizons.
Benefits for Delegates:
1. Knowledge Enhancement: Gain increased knowledge and understanding in vaccine research, supporting professional development.
2. Refreshing Experience: Attending conferences provides a refreshing and energizing experience, revitalizing your passion for research and learning.
3. Innovation Support: Support the development of new approaches and philosophies in vaccine research, contributing to industry advancements.
4. Networking Opportunities: Connect with scholars and practitioners in vaccine research, fostering collaboration and sharing of new perspectives.
Join us at VACCINE CONGRESS 2024 for a transformative experience in vaccine research and innovation!
Planning a trip to Madrid, Spain? Attend our Meeting!
Issue with VISA?
To support participants in their VISA application process, we provide VISA support documents as follows:
1. Official Letter of Invitation
2. Official Letter of Abstract Acceptance
3. Receipt of Payment
Points to note:
- Visa Letter (official letter of invitation) will be issued only after successful registration and payment for the conference.
- Visa Letters can be issued only for the individual accepted to attend the conference.
- Please contact the Program Manager, Josephine, via vaccine@euroannualmeetings.com to arrange for a Visa Letter.
Kindly provide us with the following information for Visa Letters:
- Your name as it appears on your passport
- Passport Scan Copy (for passport number and date of birth)
- Abstract Acceptance letter for Presenters
Payment Methods:
1. Payment Gateway/RAZORPAY
2. Bank-to-Bank transfer
Having trouble with registration?
Please contact Program Manager Josephine via vaccine@euroannualmeetings.com. The VACCINE 2024 team will provide you with an INVOICE for the requested price, enabling you to make the Bank-to-Bank transfer.
Conference Highlights
- COVID19 Vaccines
- Vaccines Epidemiology
- Vaccines Immunology
- Vaccine Safety
- Novel Vaccine Platforms
- Immunology of Vaccines
- Vaccine Manufacturing
- Vaccine Delivery Systems
- Vaccine Hesitancy
- Global Vaccine Access
- Paediatric Vaccines
- Geriatric Vaccines
- Vaccine Adjuvants
- Vaccine Development for Emerging Diseases
- Vaccine Immunogenicity
- Vaccine Policy and Regulation
- Next Generation Vaccines
- Vaccine Clinical Trials
- Vaccine Financing
- Vaccine Equity
- Vaccine Surveillance
- One Health Approach
- Cancer BioMarker vaccine
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | September 09-10, 2024 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- Journal of Clinical and Cellular Immunology
- Immunology: Current Research
- Journal of Vaccines & Vaccination
Abstracts will be provided with Digital Object Identifier by